echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Diabetes Care: Dulaglutide can reduce HbA1c regardless of fat or thin, with or without microvascular disease

    Diabetes Care: Dulaglutide can reduce HbA1c regardless of fat or thin, with or without microvascular disease

    • Last Update: 2022-04-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Lowering blood sugar can reduce the symptoms of hyperglycemia and many long-term complications of diabetes


    diabetes


    Addition of dulaglutide 1.


    Changes from baseline in HbA1c during treatment and up to 72 months were assessed before and after adjustment for diabetes duration, prior microvascular disease (nephropathy or retinopathy), and BMI


    The results showed that HbA1c was significantly lower in patients treated with duraglutide compared with placebo over the 72-month treatment period (least squares mean difference = -0.


    Patients receiving duraglutide had significantly lower HbA1c compared with placebo (least squares mean difference = -0.


    , but the mean HbA1c value in the duraglutide group was still lower than baseline and lower than the mean HbA1c value in the placebo group


    CONCLUSIONS: Dulaglutide 1.


    CONCLUSIONS: Dulaglutide 1.


    references:

    HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial.


    HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial.


    Leave a Comment
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.